Gemifloxacin Mesylate 1 g | ≥98% LKT Laboratories, Inc. Fluoroquinolone; bacterial DNA gyrase inhibitor. More Information Supplier Page × Gemifloxacin Mesylate
Tozasertib 250 mg | ≥98% LKT Laboratories, Inc. AurK, FLT3, Abl inhibitor. More Information Supplier Page × Tozasertib
Tozasertib 100 mg | ≥98% LKT Laboratories, Inc. AurK, FLT3, Abl inhibitor. More Information Supplier Page × Tozasertib
Tozasertib 25 mg | ≥98% LKT Laboratories, Inc. AurK, FLT3, Abl inhibitor. More Information Supplier Page × Tozasertib
Vardenafil Dihydrochloride 100 mg | ≥98% LKT Laboratories, Inc. PDE5 inhibitor. More Information Supplier Page × Vardenafil Dihydrochloride
Vardenafil Dihydrochloride 25 mg | ≥98% LKT Laboratories, Inc. PDE5 inhibitor. More Information Supplier Page × Vardenafil Dihydrochloride
Canertinib Dihydrochloride 250 mg | ≥98% LKT Laboratories, Inc. EGFR inhibitor. More Information Supplier Page × Canertinib Dihydrochloride
Canertinib Dihydrochloride 100 mg | ≥98% LKT Laboratories, Inc. EGFR inhibitor. More Information Supplier Page × Canertinib Dihydrochloride
Canertinib Dihydrochloride 25 mg | ≥98% LKT Laboratories, Inc. EGFR inhibitor. More Information Supplier Page × Canertinib Dihydrochloride
Cediranib 250 mg | ≥98% LKT Laboratories, Inc. VEGFR inhibitor. More Information Supplier Page × Cediranib
